Wonkwang University Medical School Gastrointestinal Disease Research Institute - DCN Bio Research Collaboration 'Agreement'

Joint Research on Probiotics and Gut Microbiota Functional Evaluation

[Asia Economy Honam Reporting Headquarters Reporter Lee Geon-ju] The Digestive Disease Research Institute of Wonkwang University College of Medicine in Jeonbuk and DNC Bio, a company specializing in probiotic development, have signed an agreement for "preclinical research on gut microbiota based on the Microbiome-Gut-Brain axis theory and probiotic development."

The signing ceremony was held on the 19th at the conference room of Wonkwang University College of Medicine. Through this agreement, both institutions plan to screen new probiotic candidate strains through animal experiments using various disease models and develop new products using strains whose efficacy has been verified.

Additionally, they will closely collaborate on the performance verification process of the gut microbiota function evaluation device currently being developed by DNC Bio.

Director Lee Moon-young stated, "The Wonkwang Digestive Disease Research Institute, a leading institution in the field of gastrointestinal functional diseases, is a multidisciplinary research institute composed of physiology, pathology, and other fields. Through international exchanges with institutions such as the University of Nevada, it is recognized as the most suitable research institute for product development based on the Microbiome-Gut-Brain axis theory."

A DNC Bio official said, "The personnel and infrastructure possessed by the Wonkwang Digestive Disease Research Institute play a significant role in the preclinical research process necessary for domestic gastrointestinal disease research and new drug development," adding, "We also plan to discover candidate strains in connection with multidisciplinary clinical doctors at Wonkwang University Hospital."

Meanwhile, as part of this project, Wonkwang University has completed patient recruitment for a preliminary clinical study jointly conducted with Professor Park Hyun-young of the Department of Neurology to confirm changes in gut bacteria in Korean Parkinson's patients. They plan to develop highly effective probiotics aimed at overseas market expansion and elevate domestic bio-sector technology to an international level.

This content was produced with the assistance of AI translation services.